Trademark to be used for marketing campaign for Prospera Credit Union

Trademarking future strong for Prospera, an existing credit union. We want to use it in a campaign.

We would like to trademark "Future Strong" to use in a marketing campaign for the credit union, Prospera Credit Union.

This trademark will be used in a marketing campaign for Prospera Credit Union, a financial institution

Clothing, namely pants, jeans, and shorts

Retail store and online retail store services featuring customization and personalization of clothing at the direction of customers.

Providing educational research-related reports, articles and papers to businesses, governments and academia in the fields of economy, technology, innovation, sustainability and public administration

Chemicals and adhesives

Paints, varnishes and lacquers

Freight transportation by truck; supply chain logistics and reverse logistics services consisting of the transportation of goods for others by air, rail, ship or truck; supply chain logistics and reverse logistics services for the transportation of goods for others by air, rail, ship or truck; truck and trailer rental; truck hauling; truck transport; trucking services

Chemical reagents for use in the degradation of proteins for in vitro and in vivo use; cell culture reagents for non-medical purposes; biomedical compounds, namely, polypeptides for universal masking of proteins; proteomics analysis test kits comprising reagents for detecting antibody proteins in a biological sample for scientific research purposes; diagnostic reagents for medical-scientific research use; reagents for testing the sterility of medical equipment; high purity spectroscopic solvents for spectroscopic analysis; proteomics analysis test kits comprising reagents for characterizing antibody proteins in a biological sample for scientific research purposes; proteomics analysis test kits comprising reagents for quantifying antibody proteins in a biological sample for scientific research purposes; spectroscopic solvents for laboratory spectroscopic analysis; biological assays and kits for use in fields of biological and diagnostic testing for industrial, scientific and research use; diagnostic enzymes for in vitro use in biochemistry; diagnostic enzymes for in vitro use in clinical chemistry; diagnostic enzymes for in vitro use in microbiology; diagnostic preparations for medical-scientific research use; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; chemical additives for use in enzyme stabilization; chemical additives for use in hydrothermal liquefaction processes; chemicals for use in the manufacture of solvents for laboratory analysis, other than for medical and veterinary purposes; chemical additives to insecticides; microbes as active chemical ingredients for use in the manufacture of pharmaceuticals; agricultural fertilizer; bacteria for post-harvest use in agriculture; chemicals for post-harvest use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; fertilizers, chemical products for fertilizers; plant growth hormone preparations; seed treatment chemicals for use in the manufacture of fungicides and insecticides for agricultural use; vine disease preventing chemicals; agricultural adjuvants for use with pesticides and fertilizers; biological preservatives for post-harvest use in agriculture, horticulture and forestry; biotechnologically-formed genes for use in the production of agricultural seeds to enhance plants' growth therefrom; fertilizer for agricultural use; plant growth regulating preparations; fertilizers; higher fatty acids; reagent paper for scientific or research use; artificial sweeteners

Reagent paper for medical or veterinary purposes; reagents for use in testing proteins for medical diagnostic purposes; diagnostic reagents and agents for medical diagnostic use; diagnostic reagents for clinical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting infections; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; diagnostic preparations and human therapeutics for medical use, namely, antisense oligonucleotides; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for use in the treatment of oncological, immunological, and central nervous system diseases and disorders; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical preparations for use in the treatment of inflammatory pelvic diseases; pharmaceutical preparations for use in the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for use in the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of diseases, disorders, and conditions associated with senescence, namely osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, Parkinson's disease, Alzheimer's disease, dementia, rheumatism, degenerative nerve diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; neurological pharmaceutical preparations for the prevention and treatment of Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for use in the treatment of cataracts; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for use in the treatment of infectious diseases, namely urinary tract infection, odontogenic infection and vaginal infection; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for the treatment of skin cancer; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; anti-inflammatory medications; anti-inflammatory pharmaceutical preparations; pharmaceutical anti-inflammatories; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical preparations for the treatment of oncological diseases and disorders for human use only; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders for human use only, namely, neurofibromatosis; pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective; pharmaceutical preparations for human medicine for the prevention and the treatment of central nervous system disorders; medicinal preparation, namely a synthetic octapeptide analogue of naturally occurring somatostatin, inhibiting the secretion of peptides of the gastroenteropancreatic endocrine system and of growth hormone, useful in the management of gastrointestinal endocrine tumors; pharmaceutical preparations, namely medicines for human use for the regulation of the immune system; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer; human pharmaceutical preparations for the relief of pain; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; antiviral pharmaceutical preparations; CRISPR-based pharmaceuticals for the treatment of genetic diseases; drug delivery agents in the form of compressed gum that facilitate the delivery of pharmaceutical preparations; human pharmaceutical vaccines; human pharmaceuticals for treatment of cancer; injectable pharmaceutical contraceptives; neurological and psychological pharmaceutical preparations for the treatment of chemical dependency; pharmaceutical anti-viral agents; pharmaceutical enzymes for use as gene editor for the treatment of genetic diseases and disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the prevention and treatment of diabetes; pesticides, preparations for destroying vermin, fungicides, herbicides, insecticides; preparations for destroying and combating vermin; vermin destroying preparations; agricultural herbicides; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical use; dental impression materials; dental lacquer; rubber for dental purposes; alloys of precious metals for dental purposes; alloys for dental bridges and crowns; dental abrasives, dental polish; dental enamel; dental fillings; dental materials for use with 3D printers; dental materials used to produce 3D printed try-in appliances; dental moldings; dental plasters; dental restoration material; dental sealants; dental swabs; porcelain for dental prostheses; pulp capping materials for dental purposes; protein powder nutritional supplements; acai powder dietary supplements; albumin dietary supplements; amino acid dietary supplements; vitamin and protein preparations in the form of meal replacement shakes; protein powders for meal replacement for use as a dietary supplement; quinoa protein concentrates being dietary supplements; dietary supplements for enhancing the immune system; dietary supplements for promoting weight loss; dietary supplements for reducing cholesterol; dietary, nutritional and herbal supplements for general health and well-being; iron supplements; magnesium dietary supplements; mineral supplements; nutritional supplements as a sleep aid; nutritional supplements for brain development; vitamin food supplements; medicated beverages in the nature of psilocybin botanical supplements for the treatment of mental health disorders; dietetic beverages adapted for medical purposes for the treatment of gluten intolerance and celiac disease; effervescent tablets and powders used to make electrolyte replacement beverages for medical purposes; nutraceutical food and beverages for general health and well-being; nutritional supplement meal replacement beverages containing vitamins and minerals; albumen dietary supplements for medical purposes; dietary supplements for humans containing cannabinoids for medicinal purposes; dietary supplements for general health and well-being; dietary supplements for humans containing cannabis derivatives for medicinal purposes; dietary supplements for humans containing cannabis for medicinal purposes; dietary supplements for humans containing marijuana derivatives for medicinal purposes; dietary supplements for humans containing marijuana for medicinal purposes; medicated food supplements being tablets for maintaining normal blood pressure and heart function; medicated food supplements being tablets for reducing cholesterol; nutritional additives for medical purposes namely for promoting general health and well-being, used in foods and dietary supplements for human consumption; nutritional supplements for reducing stress; nutritional supplements for relief of pain; nutritional supplements to boost the immune system; beverages for babies; food for babies; protein supplements for animals; animal feed additives for use as nutritional supplements; antibiotic food supplements for animals; dietary and nutritional supplements for pets for heart health; dietary and nutritional supplements for pets for maintaining a healthy digestive system; dietary pet supplements containing cannabis in the form of pet treats and pet food; dietary supplement for animal feed containing essential oils for the maintenance of healthy digestive functions in poultry; dietary supplement for animal feed containing essential oils for the maintenance of healthy digestive functions in swine; dietary supplements for animals containing cannabinoids for medicinal purposes; dietary supplements for animals for general health and well-being; dietary supplements for animals for skin and coat health, bone and joint health, stress reduction, and digestive health; dietary supplements for animals, namely, antioxidants; dietary supplements for pets for general health and wellbeing; melatonin supplements for pets; nutritional supplements for animals to promote energy and healthy fur, paws, and claws; pet food additives in the form of vitamin and mineral; probiotic supplements for pets; veterinarian-supervised dietary pet food

Computers; computer servers; computer hardware for data storage; computer peripheral devices, namely, keyboards, mouse, webcams, monitors, printers, scanners; downloadable and recorded computer software for digital design of images, for the digital design of animation and for image processing; downloadable and recorded computer software to enhance the audio-visual capabilities of digital images and films; downloadable and recorded computer software for operating an autonomous vehicle; downloadable and recorded computer software for car navigation systems; downloadable and recorded computer software for vehicle fleet management; downloadable and recorded computer software and hardware for vehicle fleet launching, coordinating, calibrating, directing, and managing autonomous land, sea, and sky vehicles; downloadable computer software for enabling customers and vehicles to plan and optimize their transportation movements by comparing and analyzing different modes of passenger transportation; downloadable and recorded computer software for providing the infrastructure and services to achieve smart mobility through computer visualization of the movement of people using different modes of transportation, management of the operation of vehicles, namely automobiles, buses, trucks, to optimize the mapping, routing, and directions to a person's intended destination, management of the software used to optimize the mapping, routing, and directions for personal transportation, vehicular transportation, and delivery of goods; downloadable and recorded computer software for digitalized mobility services relating to the transportation of people and the delivery of goods; downloadable and recorded computer software for digitalized mobility services relating to the computer visualization of the movement of passengers, vehicle management operation systems, to optimize the mapping, routing, and directions to a person's intended destination, management of the software used to optimize the mapping, routing, and directions for personal transportation, vehicular transportation, and delivery of goods; downloadable and recorded computer software for storing the raw data generated by automobiles and enabling the data to be easily and quickly analyzed and utilized; downloadable and recorded computer software for enabling downloads and updates of software used in vehicles via wireless networks to ensure safer and secure mobility; downloadable and recorded computer software for enabling virtual modeling of things and events in the physical world by using data collected by on-board vehicle computers, in-vehicle sensors, and external sensors; downloadable and recorded computer software for use in improving computer simulations for use in enhancing various functions of automobiles, trucks, buses.

Computer programming services; computer rental services; cloud computing web hosting services; design, creation, hosting and maintenance of internet sites for third parties; design, creation, hosting, maintenance of websites for others; hosting internet sites for others; hosting of web sites; hosting websites on the internet; rental of a database server to third parties; web hosting; rental of web servers; optimization services for computers, namely, computer networks and computer software configuration, installation of computer software; maintenance and upgrading of computer software, namely, enhancing functions of computer software, changing or adding of functions for computer software, and providing information thereon; software as a service (SAAS) service featuring software for digital design of images, for the digital design of animation and for image processing; software as a service (SAAS) service featuring software to enhance the audio-visual capabilities of digital images and films; software as a service (SAAS) service featuring software for operating an autonomous vehicle; software as a service (SAAS) service featuring software for car navigation systems; software as a service (SAAS) service featuring software for vehicle fleet management; software as a service (SAAS) service featuring software for vehicle fleet launching, coordinating, calibrating, directing, and managing autonomous land, sea, and sky vehicles; software as a service (SAAS) service featuring software for enabling customers and vehicles to plan and optimize their transportation movements by comparing and analyzing different modes of passenger transportation; software as a service (SAAS) service featuring software for providing the infrastructure and services to achieve smart mobility relating to visualization of personal movement, management of the operation of vehicles, namely automobiles, buses, trucks, to optimize the mapping, routing, and directions to a person's intended destination, management of the software used to optimize the mapping, routing, and directions for personal transportation, vehicular transportation, and delivery of goods; software as a service (SAAS) service featuring software for digitalized mobility services relating to the computer visualization of the movement of passengers, vehicle management operation systems, to optimize the mapping, routing, and directions to a person's intended destination, management of the software used to optimize the mapping, routing, and directions for personal transportation, vehicular transportation, and delivery of goods; software as a service (SAAS) service featuring software for storing the raw data generated by automobiles and enabling the data to be easily and quickly analyzed and utilized; software as a service (SAAS) service featuring software for enabling downloads and updates of vehicle software via wireless networks to ensure safer and secure mobility; software as a service (SAAS) service featuring software for enabling virtual modeling of things and events in the physical world by using data collected by on-board vehicle computers, in-vehicle sensors, and external sensors; software as a service (SAAS) service featuring software for use in improving computer simulations for use in enhancing various functions of automobiles, trucks, buses; computer software consulting; consultation services relating to computer software.